Grace Halsey

Planning to Attend FMX 2025, October 5-9? What Family Physicians Can Expect in Anaheim

September 30th 2025

Your daily dose of the clinical news you may have missed.

10 Drugs Approved for Primary Care From the First Half of 2025

The annual meeting of the American Academy of Family Physicians is a unique chance to choose continuing education on just about any topic a family physician could imagine.

Donanemab (Kisunla) Authorized in Europe for Early Symptomatic Alzheimer Disease

Review FDA-approved drugs that may soon find a place in your prescribing routine, including new treatments for UTIs, acute pain, migraine, diabetes, and more.

Novo Nordisk Resubmits Insulin Icodec Injection to FDA for Potential First Once-Weekly Basal Insulin Therapy for T2D

The European Commission granted marketing authorization for the Lilly mAb based on data from the phase 3 TRAILBLAZER-ALZ 2 and 6 clinical trials.

RSV Vaccines Found Safe and Effective Across High-Risk Groups in Cochrane Review

Novo Nordisk aims to revolutionize diabetes care with its resubmission for insulin icodec, a potential first once-weekly basal insulin for type 2 diabetes therapy in adults.

Preconception CT Scans Tied to Higher Risk of Pregnancy Loss, Congenital Anomalies: Daily Dose

Vaccines for respiratory syncytial virus were found both safe and effective across 100,000 participants and, critically, for older adults and infants.

Adult Immunization in the US: Status, Gaps, and Forward Strategy

Your daily dose of the clinical news you may have missed.

Advantages of Blood-Based Colorectal Cancer Screening: An Expert Discussion

Adult vaccine-preventable diseases cost $26.5B annually in the US. See key gaps, barriers, and strategies primary care physicians can use to boost immunization.

William Grady, MD;Sydney Jennings

FDA Approves Paltusotine as First Once-Daily, Oral Therapy for Acromegaly in Adults

William Grady, MD, highlights the convenience and compliance of blood-based tests compared to colonoscopy and stool-based tests for colorectal cancer screening.

Salt Substitute Use Rare Among Adults With HTN: Daily Dose

The approval is based on phase 3 trials showing durable IGF-1 control, symptom relief, and a favorable safety profile among adults with acromegaly.

Preventing Colon Cancer Before It Starts: Researchers Explore Novel Therapeutic Strategies

Your daily dose of the clinical news you may have missed.

William Grady, MD;Sydney Jennings

Kelly Moore, MD, MPH: A Past Voting Member of the ACIP Discusses the End of Universal Recommendation for COVID-19 Vaccination

William Grady, MD, talks about the latest research in colorectal cancer, including treatments targeting senescent cells that contribute to tumor formation.

Kelly Moore, MD, MPH;Grace Halsey

Missing First Mammogram Increases Risk for Future Breast Cancer by More Than 50%, Study Finds

Moore, president and CEO of immunize.org, has deep roots in public health and advocacy, vaccine program implementation, and immunization education.

Missing First Mammogram Increases Risk for Future Breast Cancer by More Than 50%, Population Study Finds / image courtesy of Karolinska Institutet

US CDC Reports 460% Surge in Deadly Drug-Resistant NDM-CRE Infections

Missing a first screening mammogram was associated with a 53% greater risk of stage III breast cancer and a 40% higher risk of mortality from the disease.

High-Dose Flu Vaccine Cuts Myocarditis, Pericarditis Risk in Older Adults: Daily Dose

The CDC said clinicians should be aware of these trends, select treatments carefully, and strengthen prevention efforts.

Atopic Dermatitis: The Pipeline and Clinical Approaches That Could Transform the Standard of Care

Your daily dose of the clinical news you may have missed.

Patient Care Editorial Staff

Weekly Dose Podcast: Depression Risk After Chronic Illness, Vaginal Estradiol Safety, GLP-1 Updates, Cancer Risk Reduction, and Cardiovascular Outcomes

Patient Care tapped the rich trove of research and expert perspectives from the Revolutionizing Atopic Dermatitis 2025 conference to create a snapshot of the AD care of the future.

Alcohol Use at Any Level Linked to Higher Dementia Risk, Large Study Finds

Today's episode covers depression risk after chronic illness, vaginal estradiol safety, GLP-1 updates, cancer risk, and cardiovascular outcomes.

Leucovorin Close-Up: A Primary Care Primer

A study of more than 559 000 adults and 2.4 million genetic samples found that alcohol consumption of any amount increases dementia risk, challenging prior evidence of protective effects from light drinking.

Leucovorin Up Close: Background on the Drug and Autism for Primary Care / image credit ©bacsica/stock.adobe.com

GRAIL to Showcase New Data for Galleri Multicancer Early Detection Test at Key Fall Meetings

The FDA has initiated approval of leucovorin calcium tablets for children with cerebral folate deficiency, which can manifest with autistic features. What is it?

Age and Aerobic Fitness Independently Linked to Atrial Arrhythmia Risk: Daily Dose

New data will be shared from the PATHFINDER 2 study in asymptomatic patients and the SYMPLIFY study in patients experiencing symptoms.

Pooled Cohort Equations vs PREVENT: Statin Exposure Alters ASCVD Risk Predictions

Your daily dose of the clinical news you may have missed.

Cervical Cancer Screening: What Primary Care Physicians Need to Know

The study found that although PREVENT-generated risk estimates were more consistent in a broad population, PCE estimates were more accurate in those taking statins.

Ada Stewart, MD;Sydney Jennings

Emerging Tau-Targeting Antibody for Alzheimer Disease Receives FDA Fast Track Designation

PODCAST: Family physician Ada Stewart, MD, shares practical strategies for cervical cancer screening and patient communication.

Investigational IL-2 Pathway Agonist Rezpegaldesleukin Shows Promise in Phase 2b REZOLVE-AD Trial

FDA grants Fast Track designation to etalanetug, a promising tau-targeting antibody for Alzheimer disease that could expand treatment options for the neurodegenerative disease.

Investigational IL-2 Pathway Agonist Rezpegaldesleukin Shows Promise in Phase 2b RESOLVE-AD Trial / image courtesy of George Washington University School of Medicine

HHS Ties Acetaminophen Use During Pregnancy to Autism, Despite Widely Conflicting Evidence

The findings highlight rezpegaldesleukin's novel broad-based Treg mechanism, suggesting it may be a potent option with potential for disease modification in atopic dermatitis.

Semaglutide Shows Greater CVD Risk Reduction Than Tirzepatide in Adults With Obesity: Daily Dose

The administration has initiated a nationwide public service campaign about the potential risks as professional societies quickly disputed the claims.